Company Description
Aldagen's work stems from the need for tissue repair. The biopharmaceutical company develops cell regeneration therapies using adult stem cells....
Key Aldagen Financials
| Company Type | Private - NASDAQ (GM): ALDH Proposed Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $0.2 |
| 2007 Employees | 18 |
More Aldagen Financials (4 pages)
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Aldagen's competition across multiple industries
Top Aldagen Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Aldagen Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman and CEO | W. Thomas Amick | Network | E-mail |
| CFO | David Carberry | Network | E-mail |
| President and COO | Edward L. Field | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Aldagen News
- BioWorld Today July 3, 2008 [BioWorld Today] (03 Jul 2008 00:01:00 EDT)
- METHODS FOR USING ALDHBR CELLS TO SUPPLEMENT STEM CELL TRANSPLANTATION [PCT Biblio Info] (10 Jun 2008 11:32:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.